Abnormal carnitine metabolism in hemodialysis patients on different anticoagulants

Ther Apher Dial. 2024 Jun;28(3):364-370. doi: 10.1111/1744-9987.14096. Epub 2023 Dec 12.

Abstract

Introduction: We aimed to determine whether unfractionated heparin (UH) and low molecular weight heparin (LH) contribute to aberrant carnitine metabolism in patients receiving hemodialysis.

Methods: The rate of increase in serum free fatty acids (FFAs) and the ratio of acylcarnitine to free carnitine (AC/FC) from before to after hemodialysis were determined in patients receiving UH and LH. Additionally, the effect of switching patients to UH from LH was examined.

Results: AC/FC was significantly higher in the UH group. In addition, serum FFAs in that group increased to 0.825 ± 0.270 after dialysis from 0.172 ± 0.160 before dialysis, showing a positive correlation with AC/FC. Furthermore, AC/FC was observed to be significantly higher in patients who were switched to UH from LH at 3 months after the change.

Conclusion: Compared with UH, LH has a lesser effect on lipid metabolism, suggesting that it also has a lesser effect on carnitine metabolism.

Keywords: AC/FC ratio; FFA; carnitine metabolism; hemodialysis; heparin.

MeSH terms

  • Aged
  • Anticoagulants* / pharmacology
  • Carnitine* / analogs & derivatives*
  • Carnitine* / blood
  • Fatty Acids, Nonesterified / blood
  • Fatty Acids, Nonesterified / metabolism
  • Female
  • Heparin
  • Heparin, Low-Molecular-Weight
  • Humans
  • Lipid Metabolism / drug effects
  • Male
  • Middle Aged
  • Renal Dialysis* / methods

Substances

  • Carnitine
  • Anticoagulants
  • Heparin
  • Heparin, Low-Molecular-Weight
  • Fatty Acids, Nonesterified
  • acylcarnitine